Where does Dyconex AG rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Dyconex AG ranks #35,083 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Dyconex AG hold?

Dyconex AG holds 7 US utility patents granted between 2016 and 2025, spanning 10 technology areas.

What is Dyconex AG's Innovation Score?

Dyconex AG has an Innovation Score of 47.6 out of 100 (top 18% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Dyconex AG focus on?

Dyconex AG's top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 4 patents, ranking #794 of 1,943 assignees active in that subclass. Grants appear in 10 CPC subclasses total.

Is Dyconex AG's patent grant rate increasing or decreasing?

Dyconex AG's recent grant velocity is +400% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Dyconex AG's patents?

Dyconex AG's patents average 15.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Dyconex AG patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Dyconex AG

USPTO PatentsView assignee record - 7 granted patents across 10 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Dyconex ranks #35,083 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 10 technology areas.

#35,083
of 49,997 US assignees by volume: Top 18%
by Innovation Score (47.6/100): 15.4
avg claims per patent: +400%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R35083 · Foreign Corporation #35,083 · 7 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 7 grants
MID-PACK #35,083/49,997
PHOTO-FINISH Dunlop Oil & Marine
CPC-FOCUS A61N · 10 areas
INNOV-PAR 47.6/100
CLAIMS-RICH 15.4 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +400% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Dunlop Oil & Marine Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Dyconex’s 47.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.2 pts (15%) Velocity 20.0 pts (42%) Breadth 11.2 pts (23%) Claim depth 9.3 pts (19%)

Qualcomm Incorporated · highest

85
Dyconex · this assignee

48
3D Lighting… · lowest

7

What this shows Dyconex's Innovation Score is 47.6/100 (top 18% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Dyconex?

Each dot is one of Dyconex’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Dyconex’s own 15.4 claims/patent is ABOVE the 13.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Dyconex vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Dyconex's grants concentrate

Dyconex AG is a focused PatentsView assignee: 10 CPC subclasses with 57.1% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2022 (2 grants) versus a trough of 1 in 2016. By volume, Dyconex sits between Dunlop Oil & Marine Ltd. and Dynomax Drilling Tools Inc..

Dyconex's three-year grant acceleration

Dyconex AG shows 4 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Dunlop Oil & Mari…

7
Durafuse Frames

7
Duvas

7
Dwellwell Analyti…

7
Dyna-tech Sales

7
Dynamic Mesh Netw…

7
Dynex

7
Dynomax Drilling…

7
Dyconex ◀

7

What this shows Dyconex holds 7 patents at rank #35,082, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Dyconex

By rank, the assignees closest to #35,082 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Dyconex's primary technology class.

Dyconex's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

48 Top 18% higher than 82% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Dyconex AG patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	14.3%
2021	1	14.3%
2022	2	28.6%
2023	1	14.3%
2024	1	14.3%
2025partial year	1	14.3%

Which technologies does Dyconex AG patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 4

H05K - Printed CIRCUITS; Casings OR Constructional Details OF Electric APPARATUS; Manufacture OF Assemblages OF Electrical Components 3

A61B - DIAGNOSIS; SURGERY; Identification 2

H01L - Semiconductor Devices NOT Covered BY Class H10 2

B81B - Microstructural Devices OR Systems, e.g. Micromechanical Devices 1

B81C - Processes OR Apparatus Specially Adapted FOR THE Manufacture OR Treatment OF Microstructural Devices OR Systems 1

G01R - Measuring Electric VARIABLES; Measuring Magnetic Variables 1

G01L - Measuring Force, Stress, Torque, Work, Mechanical Power, Mechanical Efficiency, OR Fluid Pressure 1

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 1

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 1

Top 10 of 10 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Dyconex AG's patent record in context - here's where to go next.

Dyconex AG's lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 57.1% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #35,083 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Dyconex AG against Dunlop Oil & Marine Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 47.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.